 Katja Aviszus
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocyte Subsets | 3 | 2020 | 69 | 0.600 |
Why?
| | Immunologic Memory | 2 | 2007 | 239 | 0.360 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2007 | 30 | 0.350 |
Why?
| | Immunoglobulin Variable Region | 7 | 2011 | 62 | 0.310 |
Why?
| | B-Lymphocytes | 6 | 2015 | 610 | 0.290 |
Why?
| | Cell Differentiation | 3 | 2007 | 1332 | 0.280 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 4 | 2013 | 15 | 0.220 |
Why?
| | PPAR gamma | 1 | 2022 | 135 | 0.220 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 68 | 0.210 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 55 | 0.210 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 44 | 0.210 |
Why?
| | Engineering | 8 | 2018 | 47370 | 0.210 |
Why?
| | Social Responsibility | 8 | 2018 | 47385 | 0.210 |
Why?
| | Attitude | 8 | 2018 | 47516 | 0.210 |
Why?
| | Students | 8 | 2018 | 47688 | 0.210 |
Why?
| | Immunoglobulin G | 4 | 2017 | 551 | 0.190 |
Why?
| | T-Lymphocyte Subsets | 2 | 2015 | 334 | 0.190 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2020 | 474 | 0.180 |
Why?
| | Berylliosis | 1 | 2020 | 183 | 0.180 |
Why?
| | Genes, Immunoglobulin | 3 | 2003 | 23 | 0.180 |
Why?
| | Antigen-Antibody Complex | 1 | 2017 | 66 | 0.170 |
Why?
| | Clonal Anergy | 2 | 2007 | 40 | 0.160 |
Why?
| | Autoimmunity | 2 | 2013 | 541 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2017 | 769 | 0.150 |
Why?
| | Mice, Inbred A | 4 | 2011 | 50 | 0.140 |
Why?
| | Interleukin-4 | 1 | 2015 | 170 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 133 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 901 | 0.140 |
Why?
| | Spleen | 1 | 2015 | 401 | 0.140 |
Why?
| | Germ-Line Mutation | 2 | 2005 | 89 | 0.120 |
Why?
| | Mice | 12 | 2017 | 11250 | 0.120 |
Why?
| | Hybridomas | 3 | 2007 | 177 | 0.120 |
Why?
| | Self Tolerance | 1 | 2011 | 16 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2011 | 1499 | 0.110 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2011 | 81 | 0.110 |
Why?
| | Young Adult | 9 | 2020 | 55149 | 0.100 |
Why?
| | Hemocyanins | 2 | 2007 | 63 | 0.100 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2011 | 141 | 0.100 |
Why?
| | Socialization | 8 | 2018 | 47368 | 0.100 |
Why?
| | Interviews as Topic | 8 | 2018 | 47819 | 0.100 |
Why?
| | Curriculum | 8 | 2018 | 47915 | 0.100 |
Why?
| | Longitudinal Studies | 8 | 2018 | 49312 | 0.100 |
Why?
| | Surveys and Questionnaires | 8 | 2018 | 50539 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 921 | 0.100 |
Why?
| | Immune Tolerance | 2 | 2017 | 263 | 0.100 |
Why?
| | Adult | 9 | 2020 | 70001 | 0.100 |
Why?
| | Immunoglobulin kappa-Chains | 3 | 2011 | 20 | 0.100 |
Why?
| | Macrophages | 2 | 2022 | 955 | 0.100 |
Why?
| | Adolescent | 8 | 2018 | 60563 | 0.090 |
Why?
| | Adoptive Transfer | 3 | 2017 | 183 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 3748 | 0.090 |
Why?
| | Humans | 14 | 2022 | 128242 | 0.090 |
Why?
| | Male | 10 | 2020 | 90667 | 0.090 |
Why?
| | p-Azobenzenearsonate | 1 | 2007 | 2 | 0.090 |
Why?
| | Antibody-Producing Cells | 1 | 2007 | 20 | 0.090 |
Why?
| | Female | 10 | 2020 | 92196 | 0.090 |
Why?
| | Haptens | 1 | 2007 | 20 | 0.090 |
Why?
| | Antibody Affinity | 1 | 2007 | 38 | 0.090 |
Why?
| | Immunization, Secondary | 1 | 2007 | 45 | 0.090 |
Why?
| | CD40 Ligand | 1 | 2007 | 37 | 0.090 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2005 | 48 | 0.090 |
Why?
| | Antibody Specificity | 1 | 2007 | 134 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2011 | 562 | 0.090 |
Why?
| | Animals | 12 | 2017 | 25325 | 0.080 |
Why?
| | Antibody Diversity | 1 | 2005 | 13 | 0.080 |
Why?
| | Autoantibodies | 2 | 2015 | 886 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2007 | 537 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 1914 | 0.070 |
Why?
| | Immunoglobulin mu-Chains | 1 | 2003 | 3 | 0.070 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2005 | 187 | 0.060 |
Why?
| | Transgenes | 1 | 2003 | 136 | 0.060 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2022 | 45 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 39 | 0.060 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 66 | 0.060 |
Why?
| | CD11c Antigen | 1 | 2020 | 30 | 0.050 |
Why?
| | Lymphocyte Activation | 1 | 2004 | 816 | 0.050 |
Why?
| | Receptors, Fc | 1 | 2020 | 26 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2020 | 64 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 343 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 117 | 0.050 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 111 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2020 | 147 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 292 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2002 | 323 | 0.050 |
Why?
| | Oligonucleotides | 1 | 1999 | 118 | 0.050 |
Why?
| | Kinetics | 1 | 2021 | 1276 | 0.040 |
Why?
| | Base Sequence | 4 | 2003 | 1697 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 447 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 1756 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2017 | 40 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 1666 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2015 | 2075 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2017 | 228 | 0.040 |
Why?
| | Protein Binding | 1 | 2021 | 1545 | 0.040 |
Why?
| | B-Cell Activating Factor | 1 | 2015 | 21 | 0.040 |
Why?
| | Germinal Center | 1 | 2015 | 36 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2015 | 154 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2020 | 810 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 2277 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 2288 | 0.030 |
Why?
| | Antibodies | 1 | 2015 | 339 | 0.030 |
Why?
| | Antibodies, Antinuclear | 1 | 2013 | 53 | 0.030 |
Why?
| | Radiation Chimera | 1 | 2011 | 28 | 0.030 |
Why?
| | Mutation | 1 | 2021 | 2524 | 0.030 |
Why?
| | Codon | 2 | 2002 | 68 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2020 | 4819 | 0.030 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 263 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 243 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 3092 | 0.020 |
Why?
| | snRNP Core Proteins | 1 | 2007 | 4 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2007 | 36 | 0.020 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2007 | 21 | 0.020 |
Why?
| | Antibody Formation | 1 | 2007 | 204 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1281 | 0.020 |
Why?
| | Mice, Inbred NZB | 1 | 2005 | 16 | 0.020 |
Why?
| | Autoantigens | 1 | 2007 | 290 | 0.020 |
Why?
| | Aged | 1 | 2020 | 14374 | 0.020 |
Why?
| | Arsanilic Acid | 1 | 2003 | 2 | 0.020 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2003 | 10 | 0.020 |
Why?
| | Immunoglobulin Class Switching | 1 | 2003 | 13 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 111 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2005 | 956 | 0.020 |
Why?
| | Epitopes | 1 | 2004 | 314 | 0.020 |
Why?
| | Chromatin | 1 | 2005 | 314 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2003 | 284 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2007 | 539 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 249 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 20385 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 1637 | 0.010 |
Why?
| | Cell Lineage | 1 | 2003 | 241 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2004 | 429 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 315 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 221 | 0.010 |
Why?
| | Base Composition | 1 | 1999 | 58 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1999 | 25 | 0.010 |
Why?
| | Point Mutation | 1 | 2000 | 190 | 0.010 |
Why?
| | DNA Primers | 1 | 2000 | 416 | 0.010 |
Why?
| | RNA Splicing | 1 | 2000 | 181 | 0.010 |
Why?
| | DNA Repair | 1 | 2000 | 141 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 823 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 1999 | 497 | 0.010 |
Why?
| | RNA | 1 | 2000 | 532 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2000 | 1048 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1999 | 2051 | 0.010 |
Why?
|
|
Aviszus's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|